A histology-based model for predicting microsatellite instability in colorectal cancers

American Journal of Surgical Pathology

Volumn 34, Issue 12, 2010, Pages 1820-1829

  Hyde, Angela ^a   Fontaine, Daniel ^b   Stuckless, Susan ^a   Green, Roger ^a   Pollett, Aaron ^c   Simms, Michelle ^a   Sipahimalani, Payal ^a   Parfrey, Patrick ^a   Younghusband, Banfield ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Eastern Health Canada   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

colorectal cancer; microsatellite instability; MsPath; pathology; revised Bethesda guidelines

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; COLORECTAL TUMOR; COMPARATIVE STUDY; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MODELS, GENETIC; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 78650361869     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181f6a912     Document Type: Article

References (36)

1. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the patho-genesis of familial colorectal cancer. Science. 1993;260:812-816.
2. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351.
3. Bapat B, Noralane ML, Baron J, et al. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:967-975.
4. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
5. Carethers JM, Chauhan DP, Fink D, et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology. 1999;117:123-131.
6. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004;126:394-401.
7. Chang EY, Dorsey PB, Frankhouse J, et al. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer. Arch Surg. 2009;144:511-515.
8. De la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005;4:233-237.
9. De la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380-3387.
10. Des Guetz G, Schischmanoff O, Nicolas P, et al. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in color-ectal cancer? A systematic review with meta-analysis. Eur J Cancer. 2009;45:1890-1896.
11. Green RC, Green JS, Buehler SK, et al. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Familial Cancer. 2007;6:53-62.
12. Green SE, Chapman PD, Burn J, et al. Clinical impact of colono-scopic screening in first-degree relatives of patients with hereditary non-polyposis colorectal cancer. Br J Surg. 1995;82:1338-1340.
13. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133.
14. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69-77.
15. Guidoboni M, Gafa R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 2001;159:297-304.
16. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
17. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-5788.
18. International Agency for Research on Cancer. World Cancer Report 2008. Lyon, France: World Health Organization 2008, 374-378.
19. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
20. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology. 2000;118:829-834.
21. Jenkins MA, Hayashi S, O'Shea A, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133:48-56.
22. Jover R, Zapater P, Castells A, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009;45:365-373.
23. Knottnerus JA, van Weel C, Muris JWM. Evidence base of clinical diagnosis: evaluation of diagnostic procedures. BMJ. 2002;324:477-480.
24. Kumar S, Chang EY, Frankhouse J, et al. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator for adjuvant therapy in colon cancer. Arch Surg. 2009; 144:835-840.
25. Lukish JR, Muro K, DeNobile J, et al. Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg. 1998;227:51-56.
26. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543.
27. Popat S, Hubner R, Houlston RS. Systematic review of microsatel-lite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23: 609-618.
28. Renkonen-Sinisalo L, Aarnio M, Mecklin JP, et al. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev. 2000;24: 137-142. (Pubitemid 30427699)
29. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349:247-257.
30. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525-2538.
31. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001;10:917-923.
32. Tajima A, Hess MT, Cabrera BL, et al. The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology. 2004;127:1678-1684.
33. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96:261-268. (Pubitemid 38256271)
34. Vasen HF, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology. 2010;138:2300-2306.
35. Woods MO, Hyde AJ, Curtis FK, et al. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res. 2005;11:6853-6861.
36. Woods MO, Younghusband HB, Parfrey PS, et al. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut. 2010;59:1369-1377.